What we do?
Keith has an extensive track record in intellectual property (IP) diligence for mergers and acquisitions, spanning transactions from small-scale deals to those exceeding $1 billion for S&P 500 companies since the early 2000s. During his tenure at Edwards Lifesciences, Keith was a key member of the strategic alliance committee, providing high-level IP guidance to medical device start-ups that received investments or purchase option agreements, strategically positioning them for successful exits.
Keith’s practice offers flexibility through hourly rates or alternative equity arrangements, making his services particularly appealing to start-ups, lenders, and investors seeking tailored legal and strategic IP support.